Using a gentle, ultra-fine mist made from a precise blend of hydrating salts, FEND strengthens your upper airways' natural ability to clean the air you breathe. Over the last twenty years, founder David Edwards and his collaborators at MIT, Harvard, the NIH and other institutions have shown that topical upper airway hydration can be achieved by targeting calcium and magnesium salts to the upper airways with benefits lasting up to six hours following brief nasal inhalation. Sensory Cloud (the parent company of Fend) is a Boston-Based health tech company that aims to improve human lives one breath at a time.
Many respiratory health approaches do not leverage the preventive potential of enhancing the body's natural defenses. FEND’s method of delivering precise blends of calcium and magnesium salts directly to the upper airways offers a non-invasive, efficient, and long-lasting way to improve airway cleanliness and overall respiratory health.
By investing in FEND, we are endorsing a shift toward more natural and less intrusive health interventions. This investment is aligned with our commitment to supporting technologies that not only enhance health and well-being but do so through innovative, evidence-based strategies that prioritize safety and efficacy. FEND is at the forefront of redefining respiratory health care, making it a key addition to our portfolio of health technology advancements.
Many respiratory health approaches do not leverage the preventive potential of enhancing the body's natural defenses. FEND’s method of delivering precise blends of calcium and magnesium salts directly to the upper airways offers a non-invasive, efficient, and long-lasting way to improve airway cleanliness and overall respiratory health.
By investing in FEND, we are endorsing a shift toward more natural and less intrusive health interventions. This investment is aligned with our commitment to supporting technologies that not only enhance health and well-being but do so through innovative, evidence-based strategies that prioritize safety and efficacy. FEND is at the forefront of redefining respiratory health care, making it a key addition to our portfolio of health technology advancements.
Investors 1
Date | Name | Website |
- | Seaside Ve... | seasideven... |
Mentions in press and media 1
Date | Title | Description |
08.07.2020 | Harvard biomedical engineering professor to launch nasal spray that could reduce COVID-19 transmission risk | A new product developed by Harvard Professor of the Practice of Biomedical Engineering David A. Edwards is set to launch this fall, and claims to be able to provide a nearly 100% reduction in the particles present in exhaled air — thus redu... |